The integration of the bias dose feature in VMAT-based breast cancer radiotherapy planning offers dosimetric advantages by improving sparing of critical organs without compromising target coverage or plan quality. This study highlights the importance of incorporating bias dose planning (BDP) in multiphase breast radiotherapy, especially when sequential boosts are required and supports its suitability for adoption in routine clinical practice.
Mani et al. (Wed,) studied this question.